Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qianliexian Jiaonang is a Traditional Chinese Medicine (TCM) combination product used for the treatment of prostate-related conditions, including chronic prostatitis and benign prostatic hyperplasia (BPH). The formulation typically includes several herbal ingredients such as Pollen Typhae, Paeoniae Radix Rubra, Persicae Semen, and Salviae Miltiorrhizae Radix. These components are traditionally used to promote blood circulation, resolve blood stasis, and clear heat and toxins. Pharmacologically, the preparation is recognized for its anti-inflammatory, analgesic, and microcirculation-improving effects, which help alleviate symptoms like pelvic pain, urinary frequency, and difficulty in urination. It is a standardized generic formulation produced by multiple manufacturers in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qianliexian jiaonang.